EC Number | Application | Comment | Organism |
---|---|---|---|
2.1.1.41 | drug development | newly synthesized azasterol derivates act at sites other than 24-SMT in Trypanosoma brucei | Trypanosoma brucei rhodesiense |
2.1.1.41 | drug development | newly synthesized azasterol derivates act at sites other than 24-SMT in Trypanosoma brucei | Trypanosoma brucei brucei |
EC Number | Cloned (Comment) | Organism |
---|---|---|
2.1.1.41 | into pET28a(+) and expressed with a His tag at the amino terminus in Escherichia coli BL21(DE3) | Trypanosoma brucei brucei |
EC Number | Inhibitors | Comment | Organism | Structure |
---|---|---|---|---|
2.1.1.41 | 22,26-azasterol | - |
Trypanosoma brucei brucei | |
2.1.1.41 | 22,26-azasterol | - |
Trypanosoma brucei rhodesiense | |
2.1.1.41 | azasterol | - |
Trypanosoma brucei brucei | |
2.1.1.41 | methyl ([2-[(3S,8S,9S,10R,13S,14S,17R)-3-(acetyloxy)-10,13-dimethyl-2,3,4,7,8,9,10,11,12,13,14,15,16,17-tetradecahydro-1H-cyclopenta[a]phenanthren-17-yl]propyl]amino)acetate | - |
Trypanosoma brucei rhodesiense | |
2.1.1.41 | methyl 3-([2-[(3S,8S,9S,10R,13S,14S,17R)-3-(acetyloxy)-10,13-dimethyl-2,3,4,7,8,9,10,11,12,13,14,15,16,17-tetradecahydro-1H-cyclopenta[a]phenanthren-17-yl]propyl]amino)propanoate | - |
Trypanosoma brucei rhodesiense | |
2.1.1.41 | methyl 4-([2-[(3S,8S,9S,10R,13S,14S,17R)-3-(acetyloxy)-10,13-dimethyl-2,3,4,7,8,9,10,11,12,13,14,15,16,17-tetradecahydro-1H-cyclopenta[a]phenanthren-17-yl]propyl]amino)butanoate | - |
Trypanosoma brucei rhodesiense | |
2.1.1.41 | methyl 5-([2-[(3S,8S,9S,10R,13S,14S,17R)-3-(acetyloxy)-10,13-dimethyl-2,3,4,7,8,9,10,11,12,13,14,15,16,17-tetradecahydro-1H-cyclopenta[a]phenanthren-17-yl]propyl]amino)pentanoate | - |
Trypanosoma brucei rhodesiense | |
2.1.1.41 | methyl 6-([2-[(3S,8S,9S,10R,13S,14S,17R)-3-(acetyloxy)-10,13-dimethyl-2,3,4,7,8,9,10,11,12,13,14,15,16,17-tetradecahydro-1H-cyclopenta[a]phenanthren-17-yl]propyl]amino)hexanoate | - |
Trypanosoma brucei rhodesiense | |
2.1.1.41 | methyl 7-([2-[(3S,8S,9S,10R,13S,14S,17R)-3-(acetyloxy)-10,13-dimethyl-2,3,4,7,8,9,10,11,12,13,14,15,16,17-tetradecahydro-1H-cyclopenta[a]phenanthren-17-yl]propyl]amino)heptanoate | - |
Trypanosoma brucei rhodesiense | |
2.1.1.41 | methyl 8-([2-[(3S,8S,9S,10R,13S,14S,17R)-3-(acetyloxy)-10,13-dimethyl-2,3,4,7,8,9,10,11,12,13,14,15,16,17-tetradecahydro-1H-cyclopenta[a]phenanthren-17-yl]propyl]amino)octanoate | - |
Trypanosoma brucei rhodesiense | |
2.1.1.41 | additional information | newly synthesized azasterols methyl ([2-[(3S,8S,9S,10R,13S,14S,17R)-3-(acetyloxy)-10,13-dimethyl-2,3,4,7,8,9,10,11,12,13,14,15,16,17-tetradecahydro-1H-cyclopenta[a]phenanthren-17-yl]propyl]amino)acetate, methyl 3-([2-[(3S,8S,9S,10R,13S,14S,17R)-3-(acetyloxy)-10,13-dimethyl-2,3,4,7,8,9,10,11,12,13,14,15,16,17-tetradecahydro-1H-cyclopenta[a]phenanthren-17-yl]propyl]amino)propanoate, methyl 4-([2-[(3S,8S,9S,10R,13S,14S,17R)-3-(acetyloxy)-10,13-dimethyl-2,3,4,7,8,9,10,11,12,13,14,15,16,17-tetradecahydro-1H-cyclopenta[a]phenanthren-17-yl]propyl]amino)butanoate, methyl 5-([2-[(3S,8S,9S,10R,13S,14S,17R)-3-(acetyloxy)-10,13-dimethyl-2,3,4,7,8,9,10,11,12,13,14,15,16,17-tetradecahydro-1H-cyclopenta[a]phenanthren-17-yl]propyl]amino)pentanoate, methyl 6-([2-[(3S,8S,9S,10R,13S,14S,17R)-3-(acetyloxy)-10,13-dimethyl-2,3,4,7,8,9,10,11,12,13,14,15,16,17-tetradecahydro-1H-cyclopenta[a]phenanthren-17-yl]propyl]amino)hexanoate, methyl 7-([2-[(3S,8S,9S,10R,13S,14S,17R)-3-(acetyloxy)-10,13-dimethyl-2,3,4,7,8,9,10,11,12,13,14,15,16,17-tetradecahydro-1H-cyclopenta[a]phenanthren-17-yl]propyl]amino)heptanoate, and methyl 8-([2-[(3S,8S,9S,10R,13S,14S,17R)-3-(acetyloxy)-10,13-dimethyl-2,3,4,7,8,9,10,11,12,13,14,15,16,17-tetradecahydro-1H-cyclopenta[a]phenanthren-17-yl]propyl]amino)octanoate, none show any significant inhibition against the recombinant enzyme | Trypanosoma brucei brucei |
EC Number | Organism | UniProt | Comment | Textmining |
---|---|---|---|---|
2.1.1.41 | Trypanosoma brucei brucei | Q45KX5 | - |
- |
2.1.1.41 | Trypanosoma brucei brucei 427 | Q45KX5 | - |
- |
2.1.1.41 | Trypanosoma brucei rhodesiense | - |
- |
- |
2.1.1.41 | Trypanosoma brucei rhodesiense STIB900 | - |
- |
- |
EC Number | Source Tissue | Comment | Organism | Textmining |
---|---|---|---|---|
2.1.1.41 | additional information | approximately 3fold higher levels are present in procyclic forms than in bloodstream forms, existence of active enzyme in both forms of the parasite | Trypanosoma brucei brucei | - |
EC Number | Specific Activity Minimum [µmol/min/mg] | Specific Activity Maximum [µmol/min/mg] | Comment | Organism |
---|---|---|---|---|
2.1.1.41 | 0.00000082 | - |
bloodstream forms | Trypanosoma brucei brucei |
2.1.1.41 | 0.00000217 | - |
procyclic forms | Trypanosoma brucei brucei |
EC Number | Substrates | Comment Substrates | Organism | Products | Comment (Products) | Rev. | Reac. |
---|---|---|---|---|---|---|---|
2.1.1.41 | desmosterol + S-adenosyl-L-methionine | - |
Trypanosoma brucei rhodesiense | 24-methylenedesmosterol + S-adenosyl-L-homocysteine | - |
? | |
2.1.1.41 | desmosterol + S-adenosyl-L-methionine | - |
Trypanosoma brucei brucei | 24-methylenedesmosterol + S-adenosyl-L-homocysteine | - |
? | |
2.1.1.41 | desmosterol + S-adenosyl-L-methionine | - |
Trypanosoma brucei rhodesiense STIB900 | 24-methylenedesmosterol + S-adenosyl-L-homocysteine | - |
? | |
2.1.1.41 | desmosterol + S-adenosyl-L-methionine | - |
Trypanosoma brucei brucei 427 | 24-methylenedesmosterol + S-adenosyl-L-homocysteine | - |
? |
EC Number | Synonyms | Comment | Organism |
---|---|---|---|
2.1.1.41 | 24-SMT | - |
Trypanosoma brucei rhodesiense |
2.1.1.41 | 24-SMT | - |
Trypanosoma brucei brucei |
2.1.1.41 | DELTA24-sterol methyltransferase | - |
Trypanosoma brucei rhodesiense |
2.1.1.41 | DELTA24-sterol methyltransferase | - |
Trypanosoma brucei brucei |
EC Number | IC50 Value | IC50 Value Maximum | Comment | Organism | Inhibitor | Structure |
---|---|---|---|---|---|---|
2.1.1.41 | 0.00176 | - |
recombinant enzyme | Trypanosoma brucei brucei | azasterol | |
2.1.1.41 | 0.00243 | - |
native enzyme | Trypanosoma brucei brucei | azasterol |